Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
CA 2237891 C · Owner: Brentano, Steven T. · Inventors: Hammond, Philip W.; Carter, Nick M.; Gordon, Patricia
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention describes oligonucleotides targeted to HPV Type 16 and/or Type 18 nucleic acid sequences which are particularly useful to aid in detecting HPV Type 16 and or 18. The oligonucleotides can aid in detecting HPV Type 16 and/or Type 18 in different ways such as by acting as hybridization assay probes helper probes, and/or , amplification primers.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 12, 1996 and granted July 30, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 12, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 12, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.